ENDPOINTS

AstraZeneca, CSPC Pharmaceuticals ink AI drug development deal for $110M upfront 

AstraZeneca is further tightening its relationship with China, with the drugmaker announcing its new research partnership with CSPC Pharmaceuticals on Friday. CSPC will receive $110 million upfront for the partners to develop preclinical oral candidates ...

Jun 13, 2025 - 12:00
 0
AstraZeneca, CSPC Pharmaceuticals ink AI drug development deal for $110M upfront 
AstraZeneca is further tightening its relationship with China, with the drugmaker announcing its new research partnership with CSPC Pharmaceuticals on Friday. CSPC will receive $110 million upfront for the partners to develop preclinical oral candidates ...
Read More

Tags:

Previous Article

Study finds airborne particles can reduce cyclone intensity in early stages

Next Article

Reach Invites High Intensity VR Action With Open Arms

Related Posts

Cullinan's deal for T cell engager from China; Kardigan buys late-stage heart drug

Cullinan's deal for T cell engager from China; Kardigan...

Jun 5, 2025  0

RFK Jr. spars with senators over HHS budget and research cuts

RFK Jr. spars with senators over HHS budget and researc...

May 20, 2025  0

CRISPR patent spat revived by federal appeals court ruling

CRISPR patent spat revived by federal appeals court ruling

May 13, 2025  0